Analysis of the cutting-edge legal issues impacting the regulation of the U.S. banking and financial services industry.
Tax strategies for business owners - and those who advise or support them.
Legal issues encountered by banks, finance companies, and other lending institutions in litigation and bankruptcy proceedings.
Tips, tricks, and tactics for handling cybersecurity situations, along with analysis of recent cybersecurity case law, statutes, and regulations.
As innovation and technology continue to transform health care, our multidisciplinary digital health team will explore the range of issues and topics in Digital Health Dispatch.
Emerging litigation trends and challenges facing companies in the food, beverage, and supplement industries, plus relevant legislative and regulatory developments.
Legal analysis about a variety of California commercial real estate issues, including the acquisition, management, and disposition of real property throughout the Golden State.
Updates and insights on the latest legal developments affecting the health care industry, from Medicare/Medicaid to cybersecurity.
Resources and legal analysis for photographers and users of photographs about the copyright laws and doctrines applicable to photographs.
Business law basics with an Internet law twist, with extensive coverage of other legal issues related to the creation, publication and dissemination of information via the Internet.
Legal and regulatory updates for the life sciences industry, plus analysis of the latest activity by the U.S. FDA, U.S. Dept.of Agriculture, FTC, DEA, and other related regulatory bodies.
Legal analysis of the top-of-mind issues affecting the higher education community as it navigates a fast-changing and complex regulatory environment.
News and discussion about sweepstakes, contests, and other promotions, plus information about the enforcement of sweepstakes laws across the country and around the world.
News and commentary on the jumble of local and state regulations that must be navigated by companies and investors involved in the burgeoning medical cannabis industry.
Thompson Coburn's Lobbying & Policy group decodes "wonky" Washington terms by giving you a straightforward definition of political lingo that is in the news.
Although we would like to hear from you, we cannot represent you until we know that doing so will not create a conflict of interest. Also, we cannot treat unsolicited information as confidential. Accordingly, please do not send us any information about any matter that may involve you until you receive a written statement from us that we represent you (an ‘engagement letter’).
By clicking the ‘ACCEPT’ button, you agree that we may review any information you transmit to us. You recognize that our review of your information, even if you submitted it in a good faith effort to retain us, and, further, even if you consider it confidential, does not preclude us from representing another client directly adverse to you, even in a matter where that information could and will be used against you. Please click the ‘ACCEPT’ button if you understand and accept the foregoing statement and wish to proceed.